Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 101

1.

Maternal RhD heterozygous genotype is associated with male biased secondary sex ratio.

Kaňková Š, Flegr J, Toman J, Calda P.

Early Hum Dev. 2019 Sep 6:104864. doi: 10.1016/j.earlhumdev.2019.104864. [Epub ahead of print]

PMID:
31500940
2.

Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta.

Collins SL, Alemdar B, van Beekhuizen HJ, Bertholdt C, Braun T, Calda P, Delorme P, Duvekot JJ, Gronbeck L, Kayem G, Langhoff-Roos J, Marcellin L, Martinelli P, Morel O, Mhallem M, Morlando M, Noergaard LN, Nonnenmacher A, Pateisky P, Petit P, Rijken MJ, Ropacka-Lesiak M, Schlembach D, Sentilhes L, Stefanovic V, Strindfors G, Tutschek B, Vangen S, Weichert A, Weizsäcker K, Chantraine F; International Society for Abnormally Invasive Placenta (IS-AIP).

Am J Obstet Gynecol. 2019 Jun;220(6):511-526. doi: 10.1016/j.ajog.2019.02.054. Epub 2019 Mar 5.

PMID:
30849356
3.

Understanding attitudes and behaviors towards cell-free DNA-based noninvasive prenatal testing (NIPT): A survey of European health-care providers.

Benachi A, Caffrey J, Calda P, Carreras E, Jani JC, Kilby MD, Klein HG, Rizzo G, Yaron Y.

Eur J Med Genet. 2019 Jan 14:103616. doi: 10.1016/j.ejmg.2019.01.006. [Epub ahead of print]

PMID:
30654154
4.

Queue management systems are not a necessary measure for the protection of personal data.

Navrátil J, Payne J, Calda P.

Cas Lek Cesk. Summer 2018;157(3):152-154.

PMID:
30441944
5.

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA; ESC Scientific Document Group .

Eur Heart J. 2018 Sep 7;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340. No abstract available.

PMID:
30165544
6.

Fetal and neonatal alloimmune thrombocytopenia.

Neumann A, Žižka Z, Koucký M, Bolcková HT, Calda P.

Ceska Gynekol. Winter 2018;83(6):448-451.

PMID:
30848151
7.

Severe fetal growth restriction at 26-32 weeks: key messages from the TRUFFLE study.

Bilardo CM, Hecher K, Visser GHA, Papageorghiou AT, Marlow N, Thilaganathan B, Van Wassenaer-Leemhuis A, Todros T, Marsal K, Frusca T, Arabin B, Brezinka C, Derks JB, Diemert A, Duvekot JJ, Ferrazzi E, Ganzevoort W, Martinelli P, Ostermayer E, Schlembach D, Valensise H, Thornton J, Wolf H, Lees C; TRUFFLE Group.

Ultrasound Obstet Gynecol. 2017 Sep;50(3):285-290. doi: 10.1002/uog.18815. No abstract available.

8.

Outcomes of Laparoscopic Treatment in Women with Cesarean Scar Syndrome.

Dosedla E, Calda P.

Med Sci Monit. 2017 Aug 22;23:4061-4066.

9.

Effect of systemic enzymotherapy on Cesarean section scar healing.

Dosedla E, Grendelova A, Calda P.

Ceska Gynekol. Summer 2016;81(3):202-207.

PMID:
27882763
10.

Can the final sonographic assessment of the cesarean section scar be predicted 6 weeks after the operation?

Dosedla E, Calda P.

Taiwan J Obstet Gynecol. 2016 Oct;55(5):718-720. doi: 10.1016/j.tjog.2015.07.006.

11.

ISUOG Practice Guidelines: invasive procedures for prenatal diagnosis.

Ghi T, Sotiriadis A, Calda P, Da Silva Costa F, Raine-Fenning N, Alfirevic Z, McGillivray G; International Society of Ultrasound in Obstetrics and Gynecology (ISUOG).

Ultrasound Obstet Gynecol. 2016 Aug;48(2):256-68. doi: 10.1002/uog.15945. No abstract available.

12.

Differentially expressed miRNAs in trisomy 21 placentas.

Svobodová I, Korabečná M, Calda P, Břešťák M, Pazourková E, Pospíšilová Š, Krkavcová M, Novotná M, Hořínek A.

Prenat Diagn. 2016 Aug;36(8):775-84. doi: 10.1002/pd.4861. Epub 2016 Jul 18.

PMID:
27323694
13.

Pro forma for ultrasound reporting in suspected abnormally invasive placenta (AIP): an international consensus.

Alfirevic Z, Tang AW, Collins SL, Robson SC, Palacios-Jaraquemada J; Ad-hoc International AIP Expert Group.

Ultrasound Obstet Gynecol. 2016 Mar;47(3):276-8. doi: 10.1002/uog.15810. No abstract available.

14.

Performance of Droplet Digital PCR in Non-Invasive Fetal RHD Genotyping - Comparison with a Routine Real-Time PCR Based Approach.

Svobodová I, Pazourková E, Hořínek A, Novotná M, Calda P, Korabečná M.

PLoS One. 2015 Nov 12;10(11):e0142572. doi: 10.1371/journal.pone.0142572. eCollection 2015.

15.

An elevated blood glucose level and increased incidence of gestational diabetes mellitus in pregnant women with latent toxoplasmosis.

Kankova S, Flegr J, Calda P.

Folia Parasitol (Praha). 2015 Sep 21;62. pii: 2015.056. doi: 10.14411/fp.2015.056.

16.

The influence of latent toxoplasmosis on women's reproductive function: four cross-sectional studies.

Kankova S, Flegr J, Calda P.

Folia Parasitol (Praha). 2015 Jul 28;62. pii: 2015.041. doi: 10.14411/fp.2015.041.

17.

Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP).

Collins SL, Ashcroft A, Braun T, Calda P, Langhoff-Roos J, Morel O, Stefanovic V, Tutschek B, Chantraine F; European Working Group on Abnormally Invasive Placenta (EW-AIP).

Ultrasound Obstet Gynecol. 2016 Mar;47(3):271-5. doi: 10.1002/uog.14952. No abstract available.

18.

[Preeclampsia in pregnancy - prediction, prevention and further management].

Leahomschi S, Calda P.

Ceska Gynekol. 2014 Nov;79(5):356-62. Czech.

PMID:
25472453
19.

[Prenatal growth curves of the Czech population].

Polášková P, Kuběna A, Calda P.

Ceska Gynekol. 2014 Aug;79(4):276-82. Czech.

PMID:
25398148
20.

Základní a fakultativní vysetrení po porodu mrtvého plodu.

Procházka M, Mechurová A, Cepický P, Calda P.

Ceska Gynekol. 2014 Mar;79 Suppl:5. Czech. No abstract available.

PMID:
25373286

Supplemental Content

Loading ...
Support Center